FLUOCINOLONE ACETONIDE IMPLANT FOR VOGT-KOYANAGI-HARADA DISEASE: Three-Year Outcomes of Efficacy and Safety.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To investigate the efficacy and safety of fluocinolone acetonide intravitreal implant in patients with Vogt-Koyanagi-Harada disease.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Retina

Title: Retina (Philadelphia, Pa.)

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1539-2864

ISSN (Print): 0275-004X

Publication date (Electronic): Nov 2016

Volume: 36

Issue: 11

Affiliations

[1 ] *Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea; †Department of Ophthalmology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Gangwon-do, Korea; ‡Department of Ophthalmology, Northwestern University School of Medicine, Chicago, IL; and §Ocular Imaging Research and Reading Center, Omaha, NE.

Article

DOI: 10.1097/IAE.0000000000001094

PubMed ID: 27333235

SO-VID: c129910f-e351-4b9b-830b-07ceaab81575

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
Authors: Jong Park, Natalia F Callaway, Cassie A Ludwig …

See all cited by